Journal of Neuroinflammation

期刊名
Journal of Neuroinflammation

J NEUROINFLAMM

ISSN / eISSN
1742-2094 / 1742-2094
目标和范围
Journal of Neuroinflammation is an open access, peer-reviewed journal that focuses on interactions of the immune system (and especially the innate immune system) with the nervous system. This includes the roles of CNS immune mediators (such as microglia and astrocytes, and their expressed cytokines and chemokines) as well as the roles of peripheral neuro-immune interactions, T cells, monocytes, complement proteins, acute phase proteins, oxidative injury and related molecular processes.

Neuroinflammation is a rapidly expanding field that has revolutionized our understanding of chronic neurological diseases. This field has grown to encompass researchers with backgrounds in many diverse fields, including pathology, biochemistry, molecular biology, genetics, clinical medicine, and epidemiology. Important contributions to this field have come from work with populations, patients, postmortem tissues, animal models, and in vitro systems.

Journal of Neuroinflammation brings together work focusing on common pathogenic processes, and provides a forum for integrative reviews and commentaries on this field.
研究方向

免疫学

神经科学

CiteScore
15.00 查看趋势图
CiteScore 学科排名
类别 分区 排名
Neuroscience - Neurology Q1 #5/175
Neuroscience - Cellular and Molecular Neuroscience Q1 #6/90
Neuroscience - General Neuroscience Q1 #9/110
Neuroscience - Immunology Q1 #26/217
Web of Science 核心合集
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2023) 分区
IMMUNOLOGY - SCIE Q1
NEUROSCIENCES - SCIE Q1
H-index
92
出版国家或地区
ENGLAND
出版商
BioMed Central
出版周期
Irregular
出版年份
2004
年文章数
308
Open Access
YES
通讯方式
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
Record the entire submission process.
September 25, 2022 - Submitted.
October 22, 2022 - Revised, requested to return in 14 days.
(Delayed revision due to email, requested two extensions)
December 18, 2022 - Resubmitted.
January 3, 2023 - Article accepted.
January 5, 2023 - Proofreading.
Reflection: This journal has a very fast processing efficiency. Although the two reviewers had few comments, they requested important experiments to be conducted (including negative experiments and staining of different types of neural cells). Looking back, these experiments have greatly enhanced my article. Overall, the journal focuses more on neuroimmunology, and it may require providing exquisite tissue fluorescent staining for more persuasiveness. According to the new ranking of the Chinese Academy of Sciences, this journal is still in the top category 1 of medicine, indicating that this established journal on neuroinflammation still has great potential. I wish everyone good news.
2023-01-06
5.31 submission. On 9.1, received reviewer comments, which required major revisions. Fortunately, the additional experimental data requested had already been completed before the submission, so they were directly added as supplementary materials. Some parts of the experiments were rewritten and the discussion was revised within 3 weeks. In early October, minor revisions were requested by the reviewer, focusing on detail modifications. After making the revisions, the paper was accepted in mid-October. It feels like the journal values logic and research innovation, and the reviewer was quite strict. However, getting a publication during my student days is considered quite fortunate.
2021-10-12

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now